Tumour-killing liquid: safer “bridge” for patients with liver cancer
A liquid formulation can kill swathes of liver cancer cells and potentiate chemotherapy treatments, according…
Browsing: hepatocellular carcinoma
Armouring anti-cancer T cells against immunosuppressants
Duke-NUS Medical School researchers, USA, together with collaborators in Singapore, have designed armoured immune cells…
Liver cancer cells manipulate stromal cells involved in fibrosis to promote tumour growth
Hepatocellular carcinoma (HCC), frequently seen in patients with liver cirrhosis caused by alcohol abuse or…
A library of mice to look up the best liver cancer treatment
If you want to get smarter, the library is a good place to start. And…
New data on emerging treatments for liver cancer raise hope for advanced disease patients
New treatment options for people with advanced or unresectable hepatocellular carcinoma (HCC) may now be…
New models help predict liver cancer after successful hepatitis C virus (HCV) treatment
Predicting who may go on to develop hepatocellular carcinoma (HCC) after successful treatment for chronic…
Scientists develop blood test to help improve liver cancer screening
Scientists have developed a new test that can help identify people who are likely to…
New model shows how cells that cause liver cancer are created
Scientists show in-vivo and in-vitro how liver cancer stem cells are born, solving a central…
New treatment extends lives of people with most common type of liver cancer
For the first time in over a decade, scientists have identified a first-line treatment that…
FDA grants accelerated approval to nivolumab and ipilimumab combination for hepatocellular carcinoma
The Food and Drug Administration (FDA) granted accelerated approval to the combination of nivolumab and…